国际标准期刊号: 2161-0681

临床与实验病理学杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • Genamics 期刊搜索
  • 期刊目录
  • 乌尔里希的期刊目录
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Performance of Laboratory Methods for Detection of Polymyxin-Resistance in Gram-Negative Bacillus

Eliana Carolina Vespero*, Gerusa Luciana Gomes Magalhae, Marsileni Pelisson, Rayane Alves dos Santos, Joice Lopes Siqueira, Julia da Silva Pimenta, Tiago Danelli, Joao Gabriel Material Soncini, Ariane Tiemy Tizura, Daniela Frizon Alfieri and Marcia Regina Eches Perugini

Resistance to polymyxin, mediated by chromosomal mutations and plasmid-borne mcr genes, is increasingly being reported not only in clinical bacteria but also in animals, farms, foods, and the environment. In this study, we evaluated a test capable of detecting resistance to polymyxins during antimicrobial susceptibility testing by the agar dilution test. We evaluated 521 consecutive isolates from A. baumannii, P. aeruginosa and Enterobacteriaceae and 57 polymyxin-resistant K. pneumoniae. We performed tests by the agar dilution method for colistin and polymyxin B (colispot and polyspot, respectively), the Broth Micro Dilution (BMD) method, and the VITEK ® 2 automated system for colistin. The colispot and polyspot tests were evaluated in concentrations of 2.0, 4.0 and 8.0 μg/mL. Considering BMD as a reference method, 420 isolates were shown to be colistin sensitive, 158 isolates were colistin resistant, 423 isolates were sensitive to polymyxin B and 155 isolates were resistant to polymyxin B. The AUC of the ROC curve showed better performance for 4.0 μg/mL, with values of 0.9671 and 0.9568 for colispot and polyspot, respectively. The Kappa index was 0.9305 for colispot and 0.9079 for polyspot. All isolates analyzed by VITEK ® 2 exhibited ROC curves with AUC values of 0.9541 and a Kappa index of 0.9049. Colispot and polyspot at a concentration of 4.0 μg/mL had higher results than the VITEK ® 2 system. The results showed that colispot and polyspot can be used with confidence in the practice of clinical laboratories.